Shigeo Ichihashi/LinkedIn
Oct 18, 2025, 05:13
The CLARIFY IMA Study From Shigeo Ichihashi and Colleagues was Recently Published!
Vascular News shared Shigeo Ichihashi’s and colleagues latest study on LinkedIn:
“Results from a multicentre randomised controlled trial indicate that pre-emptive inferior mesenteric artery (IMA) embolisation during endovascular aneurysm repair (EVAR) does not significantly reduce aneurysm sac volume or rates of type II endoleak.
The CLARIFY IMA study from Shigeo Ichihashi (Nara Medical University, Nara, Japan) and colleagues was recently published in the European Journal of Vascular and Endovascular Surgery (EJVES) and presented at the 39th European Society for Vascular Surgery annual meeting (23–26 September, Istanbul, Türkiye).”
Read more here.
Stay updated about IMA latest news with Hemostasis Today.
-
Dec 18, 2025, 17:13Daria Camilli on EuroBloodNet and EHC Collaboration for Bleeding Disorders
-
Dec 18, 2025, 16:50Marie Cambot on Innovhem’s Quantification of The HbF/HbS Ratio for SCD
-
Dec 18, 2025, 16:26Yogesh Rathod on Hematological Issues and ICU
-
Dec 18, 2025, 16:09Carlos Doti: I’m Reminded Why ASH is Such a Powerful Close to The Year
-
Dec 18, 2025, 15:23Michael Hadley: Well-Timed ACC Statement Just Out in JACC Journals
-
Dec 18, 2025, 15:12Wolfgang Miesbach on Insights from Guy Young’s ASH2025 Session on Next-Generation Gene Therapy
-
Dec 18, 2025, 14:15Plasma-Derived Therapy for Hemophilia in The Updated European Medicines Agency’s Union List
-
Dec 18, 2025, 13:55Laurent Bertoletti: BAT-VTE is One of 7 Projects Funded Under the EFFECT Trial Call!
-
Dec 18, 2025, 13:34Alexandru Stieber Explores VEXAS Syndrome